Alcobra Ltd. to Present at Investor Conferences in December
November 24, 2014 08:00 ET
|
Alcobra Ltd.
TEL AVIV, Israel, Nov. 24, 2014 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
Alcobra Announces Third Quarter Financial Results and Provides Corporate Update
November 17, 2014 07:00 ET
|
Alcobra Ltd.
Conference Call & Webcast at 8:30 a.m. Eastern Time/5:30 a.m. Pacific Time
TEL AVIV, Israel, Nov. 17, 2014 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical...
Alcobra Ltd. to Release Third Quarter 2014 Financial Results and Host Corporate Update Conference Call and Webcast on Monday, November 17
November 06, 2014 08:00 ET
|
Alcobra Ltd.
TEL AVIV, Israel, Nov. 6, 2014 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
Alcobra Ltd. to Present at Investor Conferences in November
November 03, 2014 08:00 ET
|
Alcobra Ltd.
TEL AVIV, Israel, Nov. 3, 2014 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
Alcobra Announces Presentation of New Data From Phase III Adult ADHD Study at AACAP Annual Meeting
October 23, 2014 07:25 ET
|
Alcobra Ltd.
SAN DIEGO, Oct. 23, 2014 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive disorders,...
Alcobra Announces Topline Results From Phase III Study of MDX in Adult ADHD
October 06, 2014 06:00 ET
|
Alcobra Ltd.
Company to hold a conference call Monday, October 6, 2014 at 8:30am EDT
TEL AVIV, Israel, Oct. 6, 2014 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company...
Alcobra Announces Completion of All Patient Visits in Phase III Clinical Trial of MDX in Adult ADHD
September 19, 2014 16:21 ET
|
Alcobra Ltd.
TEL AVIV, Israel, Sept. 19, 2014 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
Alcobra Ltd. to Present at the Aegis Healthcare & Technology Conference
September 05, 2014 08:00 ET
|
Alcobra Ltd.
TEL AVIV, Israel, Sept. 5, 2014 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
Alcobra Announces Enrollment of First Patient in Phase IIb Clinical Trial of MDX in Adolescents With ADHD
September 02, 2014 08:00 ET
|
Alcobra Ltd.
TEL AVIV, Israel, Sept. 2, 2014 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
Alcobra Announces Enrollment of First Patient in Phase IIb Clinical Trial of MDX in Fragile X Syndrome
August 19, 2014 08:00 ET
|
Alcobra Ltd.
TEL AVIV, Israel, Aug. 19, 2014 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company primarily focused on the development and commercialization of its proprietary drug...